Bell2Bell Podcast featuring CEO Mel Engle and Team from Predictive Oncology Inc. (POAI) [Video Edition]
The Bell2Bell (B2B) Podcast

Bell2Bell Podcast featuring CEO Mel Engle and Team from Predictive Oncology Inc. (POAI) [Video Edition]

2021-04-21
Bell2Bell’s latest podcast features Mel Engle, newly appointed CEO of Predictive Oncology Inc. (NASDAQ: POAI), as well as CFO Bob Myers and Mark Collins, Chief Technical Officer of the company’s Helomics subsidiary. During the briefing, Engle discussed his background before passing the microphone to Myers and Collins for updates on Predictive Oncology’s financial footing, current operations and goals for 2021. “I’ve been on the board of Predictive Oncology for about four years, and, within th...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free